CCR9 and neoplasm: For the bone marrow, 17.7% of the cells represent endogenous mouse cells and 82.3% represent tumor cells, where 99.8% were CD45+CCR9+ and only the 0.02% of the tumor cells were CD45+ with a decreased expression of CCR9 (Figure 3E).